The UK National Institute for Clinical Excellence (NICE) has been asked by the government to

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 352, 2002-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Single Technology Appraisal at the UK National Institute for Health and Clinical Excellence: A Source of Evidence and Analysis for Decision Making Internationally

By Sculpher Mark  

PharmacoEconomics, Vol. 28, Iss. 5, 2010-05 ,pp. : 347-349

Adis International

Access to resources Recommend Favorite

Gender Research in the National Institute on Drug Abuse National Treatment Clinical Trials Network: A Summary of Findings

By Greenfield Shelly F.   Rosa Carmen   Putnins Susan I.   Green Carla A.   Brooks Audrey J.   Calsyn Donald A.   Cohen Lisa R.   Erickson Sarah   Gordon Susan M.   Haynes Louise   Killeen Therese   Miele Gloria   Tross Susan   Winhusen Theresa  

The American Journal of Drug and Alcohol Abuse, Vol. 37, Iss. 5, 2011-09 ,pp. : 301-312

Informa Healthcare

Access to resources Recommend Favorite

Functional Outcomes of Drug Treatment in Alzheimer's Disease: A Systematic Review and Meta-Analysis

By Hansen Richard A.  

Drugs & Aging, Vol. 24, Iss. 2, 2007-01 ,pp. : 155-167

Adis International

Access to resources Recommend Favorite

Herpes Simplex Virus Infections and Alzheimer's Disease: Implications for Drug Treatment and Immunotherapy

By Leissring M.A.   Sugarman M.C.   LaFerla F.M.  

Drugs & Aging, Vol. 13, Iss. 3, 1998-09 ,pp. : 193-198

Adis International

Access to resources Recommend Favorite